Comparison of the safety of seven iodinated contrast media

Jong Mi Seong, Nam Kyong Choi, Joongyub Lee, Yoosoo Chang, Ye Jee Kim, Bo Ram Yang, Xue Mei Jin, Ju Young Kim, Byung Joo Park

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We aimed to determine the characteristic adverse events (AEs) of iodinated contrast media (IOCM) and to compare the safety profiles of different IOCM. This study used the database of AEs reports submitted by healthcare professionals from 15 Regional Pharmacovigilance Centers between June 24, 2009 and December 31, 2010 in Korea. All reports of IOCM, including iopromide, iohexol, iopamidol, iomeprol, ioversol, iobitridol and iodixanol, were analyzed. Safety profiles were compared between different IOCM at the system organ level using the proportional reporting ratio (PRR) and 95% confidence interval (95% CI). Among a total of 48,261 reports, 6,524 (13.5%) reports were related to the use of IOCM. Iopromide (45.5%), iohexol (16.9%), iopamidol (14.3%) and iomeprol (10.3%) were identified as frequently reported media. 'Platelet, bleeding & clotting disorders' (PRR, 29.6; 95%CI, 1.9-472.6) and 'urinary system disorders' (PRR, 22.3; 95% CI, 17.1-29.1) were more frequently reported for iodixanol than the other IOCM. In conclusion, the frequency of AEs by organ class was significantly different between individual media. These differences among different IOCM should be considered when selecting a medium among various IOCM and when monitoring patients during and after its use to ensure optimum usage and patient safety.

Original languageEnglish
Pages (from-to)1703-1710
Number of pages8
JournalJournal of Korean Medical Science
Volume28
Issue number12
DOIs
StatePublished - 1 Jan 2013

Fingerprint

Contrast Media
Safety
iopromide
Iopamidol
Iohexol
ioversol
Confidence Intervals
Pharmacovigilance
Physiologic Monitoring
Patient Safety
Korea
Blood Platelets
Databases
Hemorrhage
Delivery of Health Care

Keywords

  • Adverse drug reaction reporting systems
  • Contrast media
  • Patient safety

Cite this

Seong, J. M., Choi, N. K., Lee, J., Chang, Y., Kim, Y. J., Yang, B. R., ... Park, B. J. (2013). Comparison of the safety of seven iodinated contrast media. Journal of Korean Medical Science, 28(12), 1703-1710. https://doi.org/10.3346/jkms.2013.28.12.1703
Seong, Jong Mi ; Choi, Nam Kyong ; Lee, Joongyub ; Chang, Yoosoo ; Kim, Ye Jee ; Yang, Bo Ram ; Jin, Xue Mei ; Kim, Ju Young ; Park, Byung Joo. / Comparison of the safety of seven iodinated contrast media. In: Journal of Korean Medical Science. 2013 ; Vol. 28, No. 12. pp. 1703-1710.
@article{cb0af70f4f014c3ba2435cc918cc6825,
title = "Comparison of the safety of seven iodinated contrast media",
abstract = "We aimed to determine the characteristic adverse events (AEs) of iodinated contrast media (IOCM) and to compare the safety profiles of different IOCM. This study used the database of AEs reports submitted by healthcare professionals from 15 Regional Pharmacovigilance Centers between June 24, 2009 and December 31, 2010 in Korea. All reports of IOCM, including iopromide, iohexol, iopamidol, iomeprol, ioversol, iobitridol and iodixanol, were analyzed. Safety profiles were compared between different IOCM at the system organ level using the proportional reporting ratio (PRR) and 95{\%} confidence interval (95{\%} CI). Among a total of 48,261 reports, 6,524 (13.5{\%}) reports were related to the use of IOCM. Iopromide (45.5{\%}), iohexol (16.9{\%}), iopamidol (14.3{\%}) and iomeprol (10.3{\%}) were identified as frequently reported media. 'Platelet, bleeding & clotting disorders' (PRR, 29.6; 95{\%}CI, 1.9-472.6) and 'urinary system disorders' (PRR, 22.3; 95{\%} CI, 17.1-29.1) were more frequently reported for iodixanol than the other IOCM. In conclusion, the frequency of AEs by organ class was significantly different between individual media. These differences among different IOCM should be considered when selecting a medium among various IOCM and when monitoring patients during and after its use to ensure optimum usage and patient safety.",
keywords = "Adverse drug reaction reporting systems, Contrast media, Patient safety",
author = "Seong, {Jong Mi} and Choi, {Nam Kyong} and Joongyub Lee and Yoosoo Chang and Kim, {Ye Jee} and Yang, {Bo Ram} and Jin, {Xue Mei} and Kim, {Ju Young} and Park, {Byung Joo}",
year = "2013",
month = "1",
day = "1",
doi = "10.3346/jkms.2013.28.12.1703",
language = "English",
volume = "28",
pages = "1703--1710",
journal = "Journal of Korean medical science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "12",

}

Seong, JM, Choi, NK, Lee, J, Chang, Y, Kim, YJ, Yang, BR, Jin, XM, Kim, JY & Park, BJ 2013, 'Comparison of the safety of seven iodinated contrast media', Journal of Korean Medical Science, vol. 28, no. 12, pp. 1703-1710. https://doi.org/10.3346/jkms.2013.28.12.1703

Comparison of the safety of seven iodinated contrast media. / Seong, Jong Mi; Choi, Nam Kyong; Lee, Joongyub; Chang, Yoosoo; Kim, Ye Jee; Yang, Bo Ram; Jin, Xue Mei; Kim, Ju Young; Park, Byung Joo.

In: Journal of Korean Medical Science, Vol. 28, No. 12, 01.01.2013, p. 1703-1710.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparison of the safety of seven iodinated contrast media

AU - Seong, Jong Mi

AU - Choi, Nam Kyong

AU - Lee, Joongyub

AU - Chang, Yoosoo

AU - Kim, Ye Jee

AU - Yang, Bo Ram

AU - Jin, Xue Mei

AU - Kim, Ju Young

AU - Park, Byung Joo

PY - 2013/1/1

Y1 - 2013/1/1

N2 - We aimed to determine the characteristic adverse events (AEs) of iodinated contrast media (IOCM) and to compare the safety profiles of different IOCM. This study used the database of AEs reports submitted by healthcare professionals from 15 Regional Pharmacovigilance Centers between June 24, 2009 and December 31, 2010 in Korea. All reports of IOCM, including iopromide, iohexol, iopamidol, iomeprol, ioversol, iobitridol and iodixanol, were analyzed. Safety profiles were compared between different IOCM at the system organ level using the proportional reporting ratio (PRR) and 95% confidence interval (95% CI). Among a total of 48,261 reports, 6,524 (13.5%) reports were related to the use of IOCM. Iopromide (45.5%), iohexol (16.9%), iopamidol (14.3%) and iomeprol (10.3%) were identified as frequently reported media. 'Platelet, bleeding & clotting disorders' (PRR, 29.6; 95%CI, 1.9-472.6) and 'urinary system disorders' (PRR, 22.3; 95% CI, 17.1-29.1) were more frequently reported for iodixanol than the other IOCM. In conclusion, the frequency of AEs by organ class was significantly different between individual media. These differences among different IOCM should be considered when selecting a medium among various IOCM and when monitoring patients during and after its use to ensure optimum usage and patient safety.

AB - We aimed to determine the characteristic adverse events (AEs) of iodinated contrast media (IOCM) and to compare the safety profiles of different IOCM. This study used the database of AEs reports submitted by healthcare professionals from 15 Regional Pharmacovigilance Centers between June 24, 2009 and December 31, 2010 in Korea. All reports of IOCM, including iopromide, iohexol, iopamidol, iomeprol, ioversol, iobitridol and iodixanol, were analyzed. Safety profiles were compared between different IOCM at the system organ level using the proportional reporting ratio (PRR) and 95% confidence interval (95% CI). Among a total of 48,261 reports, 6,524 (13.5%) reports were related to the use of IOCM. Iopromide (45.5%), iohexol (16.9%), iopamidol (14.3%) and iomeprol (10.3%) were identified as frequently reported media. 'Platelet, bleeding & clotting disorders' (PRR, 29.6; 95%CI, 1.9-472.6) and 'urinary system disorders' (PRR, 22.3; 95% CI, 17.1-29.1) were more frequently reported for iodixanol than the other IOCM. In conclusion, the frequency of AEs by organ class was significantly different between individual media. These differences among different IOCM should be considered when selecting a medium among various IOCM and when monitoring patients during and after its use to ensure optimum usage and patient safety.

KW - Adverse drug reaction reporting systems

KW - Contrast media

KW - Patient safety

UR - http://www.scopus.com/inward/record.url?scp=84906531950&partnerID=8YFLogxK

U2 - 10.3346/jkms.2013.28.12.1703

DO - 10.3346/jkms.2013.28.12.1703

M3 - Article

C2 - 24339697

AN - SCOPUS:84906531950

VL - 28

SP - 1703

EP - 1710

JO - Journal of Korean medical science

JF - Journal of Korean medical science

SN - 1011-8934

IS - 12

ER -

Seong JM, Choi NK, Lee J, Chang Y, Kim YJ, Yang BR et al. Comparison of the safety of seven iodinated contrast media. Journal of Korean Medical Science. 2013 Jan 1;28(12):1703-1710. https://doi.org/10.3346/jkms.2013.28.12.1703